Company
Headquarters: Launceston, TAS, Australia
A$24.3 Million
AUD as of Jan. 1, 2024
US$16.6 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products. It also retails hemp wellness and food products; and engages in the agriculture business. The company is based in Launceston, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
ECS Botanics Holdings Ltd has the following listings and related stock indices.
Stock: ASX: ECS wb_incandescent